RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
McKesson Europe Stock

McKesson Europe Equity 2024

McKesson Europe Equity

2.49 B EUR

Ticker

CLS1.HM

ISIN

DE000CLS1001

WKN

CLS100

In 2024, McKesson Europe's equity was 2.49 B EUR, a 32.87% increase from the 1.88 B EUR equity in the previous year.

McKesson Europe Aktienanalyse

What does McKesson Europe do?

The McKesson Europe AG is one of the largest pharmacy and pharmaceutical trading chains in Europe and has its roots in the USA. The company was founded in 1833 by John McKesson in New York City and initially focused on the sale of medical equipment and drugs for hospitals. Since then, the company has continuously evolved and expanded. In 2007, the company merged with the German Celesio AG and subsequently operated under the name McKesson Europe AG. The company now operates with over 1,500 pharmacies in more than 15 countries and employs over 39,000 people worldwide. The business model of McKesson Europe AG focuses on the distribution of medications and health and beauty products. The company's strategy is to offer a wide range of products and services to pharmacies, consumers, and clinics. The company is divided into various business segments. Prominent examples of these business segments are wholesale and pharmaceutical manufacturing, as well as involvement in online retail, consulting services for pharmacists and clinics, and the company is also an Apple OEP contractor. The wholesale division of McKesson Europe AG is one of the largest in Europe and supplies pharmacies, clinics, and specialized retailers throughout Europe. The company relies on efficient logistics to ensure fast and smooth delivery of ordered goods. Another key area in which McKesson Europe AG operates is pharmaceutical manufacturing. The company produces medications for patients and clinics. In addition, the company is also active in the online industry and operates various online shops for medications and beauty products. The company emphasizes high product quality and fast shipping. In the field of consulting and training, McKesson Europe AG supports pharmacies and clinics in optimizing their business processes and provides assistance in patient care and improving medical services. The portfolio of McKesson Europe AG is accordingly diverse and ranges from prescription and non-prescription medications to healthcare and beauty products, as well as medical devices and aids. Overall, McKesson Europe AG is a company with a long history and a wide portfolio of products and services that relies on efficient logistics and high quality and customer satisfaction. McKesson Europe ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing McKesson Europe's Equity

McKesson Europe's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding McKesson Europe's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating McKesson Europe's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

McKesson Europe's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in McKesson Europe’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about McKesson Europe stock

What is the equity of McKesson Europe this year?

McKesson Europe has equity of 2.49 B EUR this year.

What was the equity of McKesson Europe compared to the previous year?

The equity of McKesson Europe has increased/decreased by 32.87% increased compared to the previous year.

What impact does a high equity have on investors of McKesson Europe?

A high equity is advantageous for investors of McKesson Europe as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of McKesson Europe?

A low equity can be a risk for investors of McKesson Europe, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of McKesson Europe affect the company?

An increase in equity of McKesson Europe can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of McKesson Europe affect the company?

A reduction in equity of McKesson Europe can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of McKesson Europe?

Some factors that can affect the equity of McKesson Europe include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of McKesson Europe so important for investors?

The equity of McKesson Europe is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can McKesson Europe take to change the equity?

To change equity, McKesson Europe can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does McKesson Europe pay?

Over the past 12 months, McKesson Europe paid a dividend of 0.83 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, McKesson Europe is expected to pay a dividend of 0.83 EUR.

What is the dividend yield of McKesson Europe?

The current dividend yield of McKesson Europe is 3.4 %.

When does McKesson Europe pay dividends?

McKesson Europe pays a quarterly dividend. This is distributed in the months of September, December, December, September.

How secure is the dividend of McKesson Europe?

McKesson Europe paid dividends every year for the past 20 years.

What is the dividend of McKesson Europe?

For the upcoming 12 months, dividends amounting to 0.83 EUR are expected. This corresponds to a dividend yield of 3.4 %.

In which sector is McKesson Europe located?

McKesson Europe is assigned to the 'Health' sector.

Wann musste ich die Aktien von McKesson Europe kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of McKesson Europe from 8/1/2022 amounting to 0.83 EUR, you needed to have the stock in your portfolio before the ex-date on 8/1/2022.

When did McKesson Europe pay the last dividend?

The last dividend was paid out on 8/1/2022.

What was the dividend of McKesson Europe in the year 2023?

In the year 2023, McKesson Europe distributed 0.83 EUR as dividends.

In which currency does McKesson Europe pay out the dividend?

The dividends of McKesson Europe are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von McKesson Europe

Our stock analysis for McKesson Europe Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of McKesson Europe Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.